AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 290 filers reported holding AVANOS MED INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,403,000 | +22.4% | 161,291 | +26.6% | 0.00% | +50.0% |
| Q4 2021 | $4,416,000 | +30.1% | 127,366 | +17.0% | 0.00% | 0.0% |
| Q3 2021 | $3,395,000 | -7.5% | 108,828 | +7.8% | 0.00% | 0.0% |
| Q2 2021 | $3,670,000 | +10.5% | 100,908 | +32.9% | 0.00% | 0.0% |
| Q1 2021 | $3,321,000 | -1.2% | 75,924 | +3.7% | 0.00% | 0.0% |
| Q4 2020 | $3,360,000 | +32.8% | 73,233 | -3.8% | 0.00% | 0.0% |
| Q3 2020 | $2,530,000 | +16.1% | 76,151 | +2.7% | 0.00% | 0.0% |
| Q2 2020 | $2,180,000 | -13.9% | 74,175 | -21.1% | 0.00% | 0.0% |
| Q1 2020 | $2,532,000 | +6.6% | 94,024 | +33.4% | 0.00% | 0.0% |
| Q4 2019 | $2,375,000 | -24.4% | 70,482 | -16.0% | 0.00% | -33.3% |
| Q3 2019 | $3,143,000 | -24.5% | 83,907 | -12.1% | 0.00% | 0.0% |
| Q2 2019 | $4,162,000 | -13.3% | 95,442 | -15.1% | 0.00% | -25.0% |
| Q1 2019 | $4,798,000 | -8.3% | 112,422 | -3.7% | 0.00% | -20.0% |
| Q4 2018 | $5,231,000 | -60.9% | 116,779 | -40.2% | 0.01% | -58.3% |
| Q3 2018 | $13,366,000 | – | 195,124 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
| RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
| Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
| HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
| WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
| Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
| Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
| J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
| Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |